Optimization of Methodologies to Study Freeze/Thaw Processes in Drug Substance Bottles
Open Access
- 4 September 2024
- journal article
- research article
- Published by MDPI AG in Methods and Protocols
- Vol. 7 (5) , 68
Abstract
Biological drug substance (DS) is often frozen to enhance storage stability, prolong shelf life, and increase flexibility during manufacturing. However, the freezing and thawing (F/T) of bulk DS at the manufacturing scale can impact product quality as a result of various critical conditions, including cryo-concentration during freezing, which are influenced, among other things, by product-independent process parameters (e.g., container type, fill level, F/T equipment, and protocols). In this article, we report the optimization of two major methodologies to study product-independent process parameters in DS bottles at the manufacturing scale, namely the recording of temperature profiles and liquid sampling after thawing to quantify the concentration gradients in the solution. We report experimentally justified measuring positions for temperature recordings, especially for the selection of the last point to freeze position, and highlight the implementation of camera-assisted inspection to determine the last point to thaw and the actual thawing time. In particular, we provide, for the first time, a detailed description of the technical implementation of these two measuring set-ups. Based on the reported case studies, we recommend choosing relevant measuring positions as a result of initial equipment characterization, resulting in a resource-conscious study set-up.Keywords
Funding Information
- ten23 health and SaniSure
This publication has 25 references indexed in Scilit:
- Computational fluid dynamic simulations of temperature, cryoconcentration, and stress time during large-scale freezing and thawing of monoclonal antibody solutionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2022
- Scaling Down Large-Scale Thawing of Monoclonal Antibody Solutions: 3D Temperature Profiles, Changes in Concentration, and Density GradientsPharmaceutical Research, 2021
- Impact of freeze–thaw processes on monoclonal antibody platform process developmentBiotechnology and Bioengineering, 2021
- Cryoconcentration and 3D Temperature Profiles During Freezing of mAb Solutions in Large-Scale PET Bottles and a Novel Scale-Down DevicePharmaceutical Research, 2020
- Effect of protein cryoconcentration and processing conditions on kinetics of dimer formation for a monoclonal antibody: A case study on bioprocessingBiotechnology Progress, 2019
- The importance of heat flow direction for reproducible and homogeneous freezing of bulk protein solutionsBiotechnology Progress, 2013
- Frozen-State Storage Stability of a Monoclonal Antibody: Aggregation is Impacted by Freezing Rate and Solute DistributionJournal of Pharmaceutical Sciences, 2013
- Protein and solute distribution in drug substance containers during frozen storage and post‐thawing: A tool to understand and define freezing–thawing parameters in biotechnology process developmentBiotechnology Progress, 2010
- Mapping of solution components, pH changes, protein stability and the elimination of protein precipitation during freeze–thawing of fibroblast growth factor 20International Journal of Pharmaceutics, 2009
- Study of the Individual Contributions of Ice Formation and Freeze-Concentration on Isothermal Stability of Lactate Dehydrogenase during FreezingJournal of Pharmaceutical Sciences, 2008